FDA Grants FTA to Biomarker-Guided DB104 (liafensi...
Category : ODD/BTA/FTA Status 10 October 2024FDA Grants Fast Track Designation For Biomarker-Guided DB104 (liafensine) in Patients with Treatment...
Odd Bta Fta Status
Boehringer Gets BTA by FDA & Starts Phase III Tria...
Category : ODD/BTA/FTA Status 9 October 2024Boehringer gets US FDA breakthrough therapy designation and initiates two phase III trials in MASH f...
PTC Therapeutics’ PTC518 Huntington's Disease Prog...
Category : ODD/BTA/FTA Status 30 September 2024Overview PTC Therapeutics announced that the FDA has granted Fast Track designation to the PTC518...
Clarity Receives FDA Fast Track Designation for 64...
Category : ODD/BTA/FTA Status 24 August 2024Overview Clarity Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) h...
US FDA Grants Orphan Drug Designation to Phanes Th...
Category : ODD/BTA/FTA Status 20 August 2024US FDA grants orphan drug designation to Phanes Therapeutics’ PT217 for neuroendocrine carcino...
Latest Newsletter Post
-
TAHO Pharma Begins Patient Dosing i..
21 November 2024
-
Anixa Biosciences Begins Patient Do..
21 November 2024
-
Merck’s Phase 3 Trial of Subcutaneo..
21 November 2024
-
Foresee Pharma Gets Positive Recomm..
20 November 2024
-
EnteroBiotix Completes Patient Recr..
20 November 2024
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com